Please complete the CAPTCHA to continue
@artivabio.com
✓
4 phones found area 650 and 310
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Fred Aslan is listed as President and Chief Executive Officer at Artiva Biotherapeutics at Artiva Biotherapeutics, based in San Diego, California, United States. AeroLeads shows a work email signal at artivabio.com, phone signal with area code 650, 310, and a matched LinkedIn profile for Fred Aslan.
Fred Aslan previously worked as President and Chief Executive Officer at Artiva Biotherapeutics and Founder, Advisor at Vyttra Diagnósticos. Fred Aslan holds Master Of Business Administration (Mba) from Harvard Business School.
This section adds company-level context without repeating Fred Aslan's masked contact details.
AeroLeads found 1 current-domain work email signal for Fred Aslan. Compare company email patterns before reaching out.
Fred Aslan is a President and Chief Executive Officer at Artiva Biotherapeutics at Artiva Biotherapeutics. He possess expertise in corporate development, venture capital, start ups, entrepreneurship, private equity and 10 more skills. He is proficient in English and Portuguese.
Listed skills include Corporate Development, Venture Capital, Start Ups, Entrepreneurship, and 11 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
San Diego, California, US
Artiva's mission is to deliver to cancer patients highly effective cellular immunotherapies that are safe and immediately accessible. The company is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva was founded on the understanding that NK cells hold enormous therapeutic.
São Paulo, SP, BR
Vyttra Diagnosticos has grown to become the largest Brazilian in-vitro diagnostics (IVD) company, selling equipment and reagents to thousands of clinical laboratories across Brazil, with over 200 employees. The Company was formed via a series of acquisitions from 2013 to 2016. Vyttra today has more customers than any other IVD company in Brazil, leading.
San Francisco Bay Area, US
Silicon Valley-based not-for-profit organization with one of largest communities in the US of Brazilian professionals promoting knowledge-exchange and facilitating business between Silicon Valley and Brazil.
Sao Carlos, SP, BR
Vydence Medical has grown to become the largest Brazilian dermatology-focused medical device company with over 150 employees. The Company was initially a distributor of innovative products, such as CoolSculpting from Zeltiq, but after a merger with Industra, the leading Brazilian manufacturer of dermatology-focused medical device products, Vydence became.
San Diego, CA, US
Vividion is a biotech company developing a broad range of small molecule therapies for oncology and other high unmet need indications, mostly by targeting proteins well validated by human genetics but previously considered “undruggable” by conventional approaches. The Company is applying its pioneering synthetic chemistry and chemical proteomics universal.
Invested in biotech, medical devices and diagnostics companies. Was a co-founder and board member of Receptos Pharmaceuticals, a biotech company that listed on NASDAQ in 2013 and was subsequently acquired by Celgene for US$ 7.2 billion. Also led Venrock’s investment in Zeltiq, a medical device company in the dermatology space acquired by Allergan for.
Evaluated biotech and medical device investment opportunities.
US
Responsible for business development, strategic planning, and Head of investor relations for NASDAQ-listed public biotech company developing cancer therapeutics (subsequently acquired by Celldex). Led efforts resulting in $100 million in-licensing deal with TopoTarget A/S for a clinical-stage cancer program. Helped raise $110 million in convertible debt.
Boston, Massachusetts, US
Advised top biotech, pharmaceutical and medical device companies on strategic and operational issues. Led client teams and conducted quantitative and qualitative data analysis, market research and competitive analysis. Projects ranged from corporate strategy and commercial assessment to post merger integration and resource realignment. Clients included.
Quick answers generated from the profile data available on this page.
Fred Aslan works for Artiva Biotherapeutics.
Fred Aslan is listed as President and Chief Executive Officer at Artiva Biotherapeutics at Artiva Biotherapeutics.
AeroLeads has found 1 work email signal at @artivabio.com for Fred Aslan at Artiva Biotherapeutics.
AeroLeads has found 4 phone signal(s) with area code 650, 310 for Fred Aslan at Artiva Biotherapeutics.
Fred Aslan is based in San Diego, California, United States while working with Artiva Biotherapeutics.
Fred Aslan has worked for Artiva Biotherapeutics, Vyttra Diagnósticos, Baybrazil, Vydence Medical, and Vividion Therapeutics.
You can use AeroLeads to view verified contact signals for Fred Aslan at Artiva Biotherapeutics, including work email, phone, and LinkedIn data when available.
Fred Aslan holds Master Of Business Administration (Mba) from Harvard Business School.
Fred Aslan is listed with skills including Corporate Development, Venture Capital, Start Ups, Entrepreneurship, Private Equity, Strategy, Due Diligence, and Financial Modeling.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts